The COVID-19 pandemic highlighted the importance of genomics in our public health toolkit to prepare for and respond to pathogens with pandemic and epidemic potential. As countries build on the genomic surveillance gains from the COVID-19 pandemic, questions are arising.
Entire content available on:
Lingua
IngleseTipologia
Linee guida Novità e aggiornamentiArgomento
Covid-19 Sorveglianza Patologie emergenti Tecnologia sanitaria Malattie infettive PreparednessProfilo
Salute pubblicaPaese
USA Canada America del sud America centrale Caraibi Medio oriente Sud Pacifico Cina India Indocina Singapore Europa e UK Oceania Africa